Advanced Level Workshop on Pharmacokinetic - Pharmacodynamic Data Analysis

From: Andre Keller Date: December 01, 2014 event Source: mail-archive.com
Dear Members, You are invited to join Drs. Daniel Weiner and Johan Gabrielsson for the 16th Advanced Level Workshop on Pharmacokinetic-Pharmacodynamic Data Analysis in San Diego, CA. Secure your place by registering early and receive a 20% discount! (expires December 15th) Interested in a custom on-site training course? Follow the link to view the benefits of on-site training and to request a proposal: http://info.certara.com/contact-us-for-custom-on-site-training 16th Advanced Level Workshop on Pharmacokinetic - Pharmacodynamic Data https://www.certara.com/training/classes/72 February 17-20, 2015 San Diego, CA Register Here: https://www.certara.com/training/classes/72 Learn to apply advanced approaches for conducting PK/PD analysis. This course aims to give the course participants confidence and encouragement to have a go at PK/PD and to practice PK/PD data analysis on real life case studies from discovery, preclinical and development. The program is comprised of lectures and group exercises with discussion, combined with hands-on PK/PD data analysis sessions. Who should attend? Scientists with at least five years of experience in PK/PD modeling. Qualified graduate students. Topics include: Dose-response-time analysis, advanced principles of turnover modeling including modeling tolerance and rebound, approaches to TMDD modeling, approaches to optimizing sampling collection times, modeling PD effects for combination drug treatments, pattern recognition, and translational aspects of PK/PD modeling. Course includes: * Complimentary copy of Pharmacokinetic & Pharmacodynamic Data Analysis [with CDROM] by Johan Gabrielsson and Dan Weiner. * Lectures, group exercises with discussion, and hands-on PK/PD data analysis including population PK/PD modeling using Phoenix WinNonlin and NLME. * Discussions and exercises will enable participants to master state-of-the-art approaches to real-life problems. Daniel Weiner Ph.D. Dr. Weiner has extensive drug development experience and has served as an expert consultant to the U.S. Food and Drug Administration (FDA) on pharmacokinetic modeling and bioequivalence assessment. Prior to his previous tenure with Pharsight as a Senior Vice President, Dr. Weiner held several management positions including Head, Biostatistics, Merrell Dow Pharmaceuticals; Vice President, Statistical Consultants, Inc.; Vice President, Syntex Development Research; Senior Vice President and Principal Scientist, Quintiles, and most recently, Senior Vice President and Global Head of Clinical Development at IVAX Research. Johan Gabrielsson Ph.D. Johan Gabrielsson has been Senior Principal Scientist at AstraZeneca R&D Mölndal. His responsibilities included kinetic/dynamic related project tasks in the CV & GI & CNS & Cancer & Biologics areas. He is a co-author of the textbook 'Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications' 4th ed. (2006). He is professor of Integrative Pharmacology at the Swedish Agricultural University in Uppsala, Sweden. He is also academically affiliated with Dept. of Pharmaceutics, Univ. Tennessee and University of Manchester. He has published extensively in the field of pharmacokinetic-pharmacodynamic modelling and reasoning, and has run numerous courses internally and externally in the area of biological data analysis since 1985 in Europe, the US and Asia (>4000 participants) at both the undergraduate and graduate level. His research focuses on modelling different aspects of endogenous turnover, such as functional tolerance and rebound phenomena, physiological limits and target-mediated drug disposition in collaboration with Professor LA Peletier, Leiden University. He has been external examiner on several PhD Theses abroad. Kind regards, Andre Keller Certara(tm) 5520 Dillard Dr., Suite 260 Cary, NC 27518 Tel +1-919-852-4611 http://www.certara.com/